Professor Andrew Briggs

Andrew is a leading expert in health economic evaluation, with a particular focus on statistical methods for cost-effectiveness analysis. His work encompasses parameter estimation for economic models, cost-effectiveness analyses within clinical trials, and exploring heterogeneity in health outcomes using advanced prognostic scoring methods. In recent years, Andrew has broadened his research scope to explore environmental economic evaluation, integrating health co-benefits into analyses of environmental policies and interventions. This interdisciplinary approach reflects his commitment to addressing global challenges at the intersection of health and sustainability.

As co-chair of the Joint Society for Medical Decision Making (SMDM) and International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Modelling Methods, Andrew led the development of seven papers that have shaped best practices in medical decision-making and health technology assessment. He is the author of two widely regarded textbooks: Decision Modelling for Health Economic Evaluation (Oxford University Press) and Statistical Methods for Cost-Effectiveness Analysis (Wiley). With a career dedicated to advancing methodological research and practical applications, Andrew continues to influence academia and policy in health and beyond.